Medicaid pays for mentoring of mental health patients by “peer supporters,” but only if they are state-certified. California is one of two states with no certification program. Legislation pending in Sacramento would change that — if the governor backs it.
California lawmakers spent big on Medi-Cal in the 2019-20 state budget, voting to cover more older residents and people with disabilities, restore benefits cut during the recession and open the program to eligible young adults who are in the country illegally.
More than 95% of the Arkansas residents targeted by the state’s Medicaid work requirement were already working or met the criteria to be exempted from the mandate, according to a study in the New England Journal of Medicine.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Under a program enacted in Washington state this spring, workers can get up to $36,500 to help pay for long-term health care and services such as installing grab bars in the shower or respite care for family caregivers.
More than half of Americans contacted about an overdue bill said it related to medical debt. A federal agency has proposed new guidance for what debt collectors are allowed to do when pursuing many types of overdue consumer bills, including medical debt. But some consumer advocates have panned the effort.
Buprenorphine is becoming an increasingly popular choice among doctors in California for treating opioid addiction. Use of methadone, while still more common, has not gained ground in recent years.
Reform has a cost. But the point of a health care system is to treat patients, not to buttress the economy.
As policymakers debate how to address the high cost of prescription drugs, a new KFF analysis compares data on prescription drug spending and use across large employer plans, Medicare Part D and Medicaid, and provides context for policy discussions abo…
Prescription drug costs are a pressing concern for both consumers and policymakers. This analysis compares prescription drug spending and use in large private employer plans, Medicare Part D, and Medicaid, based primarily on claims data by payer, which…
